ChromaDex (NASDAQ: CDXC) Starts Presentation at 30th Annual ROTH Conference
ChromaDex (NASDAQ: CDXC) leverages its complementary business units to discover, acquire, develop and commercialize patented and proprietary health and wellness consumer products and ingredient technologies that promote healthy longevity. In addition to consumer product and ingredient technologies units, the company also has business units focused on natural product fine chemicals (known as “phytochemicals”), and product regulatory and safety consulting. With relationships with universities and research institutions, the company is able to discover and license early-stage, IP-backed ingredient technologies. For more information, visit the company’s website at www.chromadex.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that…







